Anson Funds Management LP Q2 2018 Filing

Filed August 14, 2018

Portfolio Value

$170.6B

Holdings

26

Report Date

Q2 2018

Filing Type

13F-HR

All Holdings (26 positions)

#StockSharesValue% PortfolioType
1
SPYSPDR S&P 500 ETF TR
251,000$68.1B39.91%Call
2
NVDANVIDIA CORP
125,300$29.7B17.40%Put
3
AMZNAMAZON COM INC
12,000$20.4B11.96%Put
4
UBNTEURUBIQUITI NETWORKS INC
144,000$12.2B7.15%Put
5
GOLDCORP INC NEW
392,125$6.7B3.91%
6
DXJWISDOMTREE TR
86,000$4.6B2.72%
7
ALTA MESA RES INC
622,006$4.2B2.48%
8
ALTA MESA RES INC
575,000$3.9B2.30%
9
RANDGOLD RES LTD
50,000$3.9B2.26%
10
TACTRANSALTA CORP
525,000$3.5B2.03%
11
MSFTMICROSOFT CORP
30,000$3.0B1.73%
12
SECOND SIGHT MED PRODS INC
1,335,561$2.2B1.30%
13
STKSTHE ONE GROUP HOSPITALITY IN
828,551$2.0B1.18%
14
CEF/USPROTT PHYSICAL GOLD & SILVE
120,000$1.5B0.88%
15
SMSISMITH MICRO SOFTWARE INC
571,312$1.3B0.77%
16
SEANERGY MARITIME HLDGS CORP
1,432,500$1.2B0.73%
17
ACASTI PHARMA INC
684,600$527.0M0.31%
18
RXI PHARMACEUTICALS CORP NEW
218,023$421.0M0.25%
19
GENIUS BRANDS INTL INC
200,000$405.0M0.24%
20
CVM1EURCEL SCI CORP
336,500$310.0M0.18%
21
ATOSEURATOSSA GENETICS INC
108,977$240.0M0.14%
22
INVIVO THERAPEUTICS HLDGS CO
54,450$93.0M0.05%
23
INSPIREMD INC
369,774$92.0M0.05%
24
INSPIREMD INC
250,000$62.0M0.04%
25
IMMUNOCELLULAR THERAPEUTICS
117,187$30.0M0.02%
26
INPIXON
181,624$29.0M0.02%